Morphological changes |
Cellular swelling, membrane rupture, and cellular contents flowing out |
Wrinkled cells, nuclear condensation, cell membrane ectropion, and apoptotic body formation |
Cell enlargement, cellular swelling, and membrane rupture |
Shrunken mitochondria, mitochondrial membrane condensation, mitochondria crista reduction, and outer mitochondrial membrane rupture, and mitochondria fragment |
Signaling pathway |
Pyroptosis pathway: caspase1-dependent pyroptosis and caspase1-independent pyroptosis |
Apoptosis pathway: extrinsic pathway (receptor-mediated) and intrinsic pathway (mitochondria-mediated); p53-mediated apoptosis pathway |
Necroptosis pathway and TNF pathway |
Ferroptosis pathway and p53 pathway |
Inhibitors |
VX765 (Chen Y. et al., 2022) |
Z-VAD FMK (Yu et al., 2022) |
Necrostatin-1 (Dong et al., 2022) |
Ferrostatin-1 (Liu et al., 2020c), liproxstatin-1 (Fan et al., 2021), DFO (Shen et al., 2022) |
Key regulators |
GSDMD, caspase-1/4/5/11, IL-1β, and IL-18 |
Fas/TNFR/TRAILR, caspase-3/8/9, Bax/Bcl-2, Cyt C, and APAF-1 |
RIP1, RIP3, MLKL, and Fas/TNFR |
GPX4, JAK, SLC7A11, ACSL4, FPN, p53, and NADPH oxidase |
Mitochondrial dysfunction |
ROS and Ca2+ overload |
Cyt C releases, BAX/BAK, and Bcl family protein interact |
ROS burst, Drp1 activation, and mitochondrial fisson |
Mitochondrial lipid peroxidation and Ca2+ overload |